Device / Technology News

RSS

Hovione's TwinCaps inhaler in phase III trials for influenza

Hovione has announced that its licensee Daiichi Sankyo has informed that it intends to use Hovione's TwinCaps dry powder inhaler device in the launch of the compound CS-8958, an inhaled long-acting neuraminidase inhibitor active against the influenza virus.

15 Apr 2009

The DECIPHER database - revolutionising clinical practice and genetic research

Today - five years after the inception of the DECIPHER database - researchers have published a report that reveals the developing role of the database in revolutionising both clinical practice and genetic research.

15 Apr 2009

A bright future for biological sensors

In the future, explained Peter Ghazal, Chair of Edinburgh University's Department of Molecular Genetics and Biomedicine, biological sensors, the product of the integration of biology and electronics will be used to detect infections and prescribe personalized treatments.

15 Apr 2009

Bracelet warns of too much sun exposure

Scientists in Britain have come up with what appears a very sensible idea - a team at Strathclyde University in Scotland have developed an early warning sunburn indicator - it comes in the form of a thin strip which turns pink after too much exposure to ultra-violet light.

15 Apr 2009

Wireless body sensors to help prevent falls in seniors

When an older person is injured in a fall, the cost is significant, both in quality of life and medical expense.

14 Apr 2009

Next generation ultra-thin materials only one molecule thick

With the human genome in hand, biochemists have cataloged the 3-D structures of thousands of proteins isolated from living cells.

14 Apr 2009

Nerve shock implant device may help bladder control in urinary incontinence

For people with urinary incontinence who have run out of options, an electrical device might help, according to a new Cochrane Library review.

14 Apr 2009

Columbia University licenses retinal imaging technology to PCAsso Diagnostics

Columbia University Science and Technology Ventures announced that it has signed a worldwide exclusive license agreement with PCAsso Diagnostics, LLC to develop and market a novel imaging technology for diagnosis of vascular leakage disorders of the retina.

13 Apr 2009

Funding boost for Bristol research on titanium bone implants

Dr Jason Mansell, Lecturer in Bone Biology, has been awarded £57,000 from the International Team for Implantology (Switzerland) for work on titanium bone implants.

12 Apr 2009

Medtronic commences abdominal aortic aneurysm stent graft study

Medtronic, Inc. has announced the start of ENGAGE, the largest ever study of its kind, which will evaluate the performance of the Endurant stent graft, an implantable medical device designed to provide an advanced minimally-invasive alternative to open surgical repair of abdominal aortic aneurysms.

9 Apr 2009

Axela launches nine plate based tumor marker assays

Available in high performance ELISA format they have been designed for stand alone use or to simplify the transition to automated dotLab assays.

9 Apr 2009

Telemonitoring changes the working practice of cardiac nurses

The 9th Annual Spring Meeting of the European Society of Cardiology Council on Cardiovascular Nursing and Allied Professions (CCNAP), organised in cooperation with the Irish Nurses Cardiovascular Association (INCA), is being held at the Royal Dublin Society, Dublin, Ireland, on 24-25 April.

8 Apr 2009

FDA to review 25 medical devices marketed prior to 1976

The FDA today announced that manufacturers of 25 types of medical devices marketed prior to 1976 must submit safety and effectiveness information to the agency so that it may evaluate the risk level for each device type.

8 Apr 2009

New nanostructured biosensors

Research and industry are increasingly exploiting the potential of aptamers.

8 Apr 2009

FDA approves label change for non-invasive fibroid treatment

InSightec Ltd. has announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.

8 Apr 2009

Mayer Laboratories acquires Today Sponge contraceptive distribution rights

Mayer Laboratories, Inc., a marketer and distributor of high-quality contraceptive and other reproductive healthcare products, has announced that it has signed an agreement with Alvogen Group for the exclusive distribution rights of the Today Sponge for the United States, Europe and Canada.

6 Apr 2009